or Try an Advanced Search...

    Technical Analysis for BIAF - bioAffinity Technologies, Inc.

    Grade Last Price % Change Price Change
    D 2.22 2.78% 0.06
    BIAF closed up 2.78 percent on Monday, July 1, 2024, on 48 percent of normal volume. It ran into resistance at its 50 day moving average.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical BIAF trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    20 DMA Support Bullish 2.78%
    MACD Bullish Signal Line Cross Bullish 2.78%
    Wide Bands Range Expansion 2.78%
    Crossed Above 20 DMA Bullish 4.23%
    Wide Bands Range Expansion 4.23%
    Gapped Up Strength 4.23%
    Older End-of-Day Signals for BIAF ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    Gap Up Closed about 10 hours ago
    Reversed from Up about 10 hours ago
    Gapped Up (Full) about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BIAF Chart by TradingView
    Basic chart:

    Profile

    bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Lung Cancer Molecular Diagnostics Cancer Therapeutics

    Is BIAF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
    May 16 bioAffinity Technologies GAAP EPS of -$0.21, revenue of $2.4M
    May 15 bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
    Apr 24 bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
    Apr 9 bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
    Apr 4 bioAffinity Technologies files to sell 1.63M shares for holders
    Apr 1 bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 8 Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
    Mar 8 bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
    Mar 6 WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
    See more BIAF news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.62
    52 Week Low 0.9548
    Average Volume 97,622
    200-Day Moving Average 1.80
    50-Day Moving Average 2.24
    20-Day Moving Average 2.11
    10-Day Moving Average 1.97
    Average True Range 0.18
    RSI (14) 54.34
    ADX 16.0
    +DI 26.83
    -DI 14.81
    Chandelier Exit (Long, 3 ATRs) 2.00
    Chandelier Exit (Short, 3 ATRs) 2.31
    Upper Bollinger Bands 2.48
    Lower Bollinger Band 1.74
    Percent B (%b) 0.65
    BandWidth 35.15
    MACD Line -0.06
    MACD Signal Line -0.08
    MACD Histogram 0.0237
    Fundamentals Value
    Market Cap 21.09 Million
    Num Shares 9.5 Million
    EPS -0.43
    Price-to-Earnings (P/E) Ratio -5.16
    Price-to-Sales 46.70
    Price-to-Book 2.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.55
    Resistance 3 (R3) 2.56 2.46 2.50
    Resistance 2 (R2) 2.46 2.38 2.46 2.48
    Resistance 1 (R1) 2.34 2.32 2.29 2.33 2.46
    Pivot Point 2.24 2.24 2.22 2.24 2.24
    Support 1 (S1) 2.12 2.16 2.07 2.11 1.98
    Support 2 (S2) 2.02 2.10 2.02 1.96
    Support 3 (S3) 1.90 2.02 1.95
    Support 4 (S4) 1.89